A clinical pharmacology study of S-888711 in thrombocytopenic patients with Child-Pugh class C liver disease
Phase 1
- Conditions
- Thrombocytopenia due to chronic liver disease
- Registration Number
- JPRN-jRCT2080223234
- Lead Sponsor
- Shionogi & Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Main inclusion criteria
Child-Pugh Class C patient with thrombocytopenia due to chronic liver disease
Exclusion Criteria
Main exclusion criteria
Patients who received blood transfusions (except for red blood cell products and albumin preparations) within 14 days prior to enrollment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method